Rajagopalan Nirmala, Suchitra Joyce B, Shet Anita, Khan Zafar K, Martin-Garcia Julio, Nonnemacher Michael R, Jacobson Jeffrey M, Wigdahl Brian
Freedom Foundation, 180 Henur Cross, Bangalore, India.
Am J Infect Dis. 2009;5(3):219-224. doi: 10.3844/ajidsp.2009.219.224.
Despite massive national efforts to scale up Antiretroviral Therapy (ART) access in India since 2004, the AIDS death rate was 17.2 per 100,000 persons during 2003-2005. In the era of HAART in resource poor settings, it is imperative to understand and address the causes of AIDS related mortality. This collaborative study aimed at defining the predictors of mortality among people living with HIV/AIDS (PLHA) admitted during 2003-2005 to the Freedom Foundation (FF) Care and Support facility, Bangalore, India. APPROACH: Fifty consecutively selected HIV-infected patients who died during the study period and 50 HIV-infected patients matched by age, gender, route of transmission, nutrition status and stage of disease who survived at least 12 months post-ART were included in this study. The impact on mortality by factors such as: Hemoglobin, CD4+T lymphocyte counts, weight loss and Opportunistic Infections (OIs) were studied. Statistical analyses were done by Chi-square, Fisher's Exact Test, Kaplan-Meier and multivariate logistic regression. RESULTS: Recurrent diarrhea was a significant risk factor for mortality (OR = 12.25, p = 0.004), followed by a diagnosis of pulmonary tuberculosis (TB) at first admission (OR = 4.86) while TB in general also negatively impacted survival (p = 0.002). Though not statistically significant, Pneumocystis carinii pneumonia, Cryptococcal meningitis and Toxoplasmosis also negatively affected survival. Mortality was high among those not on HAART (81%) while it was significantly reduced (28%) among those on HAART (p<0.001). Patients who died had elevated liver enzymes (p = 0.027) and significant weight loss (p = 0.012). Mortality was high among patients irregular with their medical follow-up (p<0.001). CONCLUSION: Interventions that facilitate early OI diagnosis and treatment especially diarrhea and TB may reduce mortality in HIV. HAART alone without proper OI management and nutrition did not prevent mortality among PLHA. In resource poor settings, it becomes imperative to focus on low cost tools and increased capacity building along with regular clinical follow-up for diagnosis and early treatment of OIs. Further studies are warranted to explore benefits of initiating HAART earlier than currently recommended.
尽管自2004年以来印度在全国范围内大力扩大抗逆转录病毒疗法(ART)的可及性,但在2003 - 2005年期间,艾滋病死亡率为每10万人中有17.2人。在资源匮乏地区的高效抗逆转录病毒治疗(HAART)时代,了解并解决与艾滋病相关的死亡原因至关重要。这项合作研究旨在确定2003 - 2005年期间入住印度班加罗尔自由基金会(FF)关爱与支持机构的艾滋病毒/艾滋病感染者(PLHA)的死亡预测因素。
本研究纳入了在研究期间死亡的50例连续入选的艾滋病毒感染患者,以及50例在年龄、性别、传播途径、营养状况和疾病阶段相匹配且在接受抗逆转录病毒治疗(ART)后至少存活12个月的艾滋病毒感染患者。研究了诸如血红蛋白、CD4 + T淋巴细胞计数、体重减轻和机会性感染(OIs)等因素对死亡率的影响。采用卡方检验、费舍尔精确检验、卡普兰 - 迈耶法和多变量逻辑回归进行统计分析。
反复腹泻是死亡的一个重要危险因素(OR = 12.25,p = 0.004),其次是首次入院时被诊断为肺结核(TB)(OR = 4.86),而一般来说肺结核也对生存有负面影响(p = 0.002)。虽然无统计学意义,但卡氏肺孢子虫肺炎、隐球菌性脑膜炎和弓形虫病也对生存有负面影响。未接受HAART的患者死亡率很高(81%),而接受HAART的患者死亡率显著降低(28%)(p<0.001)。死亡患者的肝酶升高(p = 0.027)且体重显著减轻(p = 0.012)。医疗随访不规律的患者死亡率很高(p<0.001)。
促进早期机会性感染诊断和治疗,尤其是腹泻和肺结核的干预措施可能会降低艾滋病毒感染者的死亡率。仅进行HAART而没有适当的机会性感染管理和营养支持并不能预防艾滋病毒/艾滋病感染者的死亡。在资源匮乏地区,必须注重低成本工具和加强能力建设,同时进行定期临床随访以诊断和早期治疗机会性感染。有必要进一步研究探讨比目前建议更早开始HAART的益处。